RxDoctor Payments Data

David Sutter, MD

Family Medicine · Corpus Christi, TXNPI 1659351500

Payments from drug & device makers

$706in general payments, 2019–2025

Across 36 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$208
  • Novo Nordisk$104
  • Lilly USA, LLC$57
  • Pfizer$57
  • Sanofi-aventis U.S. LLC$56
  • Dexcom, Inc.$41
  • plus $184 from 8 others

What the payments were for

  • Food & beverage$69598%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$706 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$174,960
Medicare patients
388
Services billed
3,708

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide94$119,803
FarxigaDapagliflozin Propanediol74$94,266
JanuviaSitagliptin Phosphate73$83,432
EliquisApixaban60$64,543
TrulicityDulaglutide23$39,280
MounjaroTirzepatide33$37,978
JardianceEmpagliflozin26$29,506
ProliaDenosumab16$26,223
XareltoRivaroxaban13$20,688
JanumetSitagliptin Phos/Metformin Hcl13$19,670
Repatha SureclickEvolocumab28$16,128
MyrbetriqMirabegron16$15,668
Repatha SyringeEvolocumab12$14,020
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog30$12,514
LinzessLinaclotide15$9,675

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$104$119,80394 claims
Lilly USA, LLCTrulicity, Mounjaro$57$77,25856 claims
PfizerEliquis$57$64,54360 claims
AmgenProlia$15$26,22316 claims
GSKBreo Ellipta, Trelegy Ellipta$208$17,40827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →